Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Service Provider
April 18, 2005
- OTC & HEALTH FOODS
April 18, 2005
- 2005 Will Be Remembered as Major Turning Point for Domestic Drug Industry
April 18, 2005
- 11 Organizations Registered to Certify In Vitro Diagnostics, Med. Devices
April 18, 2005
- BUSINESS FORECASTS
April 18, 2005
- Pfizer Supports Women in Stopping Smoking without Gaining Weight
April 18, 2005
- BUSINESS RESULTS
April 18, 2005
- DIAGNOSTIC NEWS IN BRIEF
April 18, 2005
- Reporter's Eye: 5
April 18, 2005
- MEDICAL DEVICE NEWS IN BRIEF
April 18, 2005
- NEW PRODUCTS
April 18, 2005
- Tanabe Seiyaku Working to Strengthen Quality Assurance System
April 18, 2005
- Nu-lotan Shows High Evidence Scores in Clinical Studies
April 18, 2005
- Diagnostic Criteria for Metabolic Syndrome Announced
April 18, 2005
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
April 18, 2005
- Give Patients More Options for Hepatitis C: Patient Spokesman
April 18, 2005
- JHSF Calls For Support for Immunotherapy for Cancer, Infectious Diseases
April 18, 2005
- Employees Not Necessarily Accepting Pay for Performance
April 18, 2005
- REGULATORY NEWS IN BRIEF
April 18, 2005
- Sales of Micardis Expected to Jump 30% in 2005: Dr Banchi of BI
April 18, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…